Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Regulatory Approval
|
Falling Comet
1120.2000
16.00
(
1.45
%)
NSE
Jun 25, 2025
15:31 PM
29.64% Fall from 52W High
Volume:
816.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
29 May 2023
Regulatory Approval
1120.20
1.45%
Aurobindo Pharma Limited
Hold:
Aurobindo Pharma Ltd.
by
ICICI Direct
Target: 615
Target
ICICI Direct
Aurobindo Pharma Ltd. is trading below all available SMAs
More from Aurobindo Pharma Ltd.
Recommended
Market closes higher, Reliance Infra bags a Rs 600 cr export order for ammunition from Rheinmetall
Trendlyne Marketwatch |
25 Jun 2025, 03:56PM
Five stocks to buy from analysts this week - June 25, 2025
The Baseline |
25 Jun 2025, 11:20AM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020